Ezz Life Science (ASX:EZZ) — Material Events
ASX:EZZ · 4 articles in the last 12 months · 100% assessed
Click a band to jump to that tier
Major ≥90
Significant 75–89
Notable 50–74
Routine <50
Not assessed
EZZ Accelerates Global Growth with US Launch and $21M Southeast Asia DealMedium
EZZ reports strong Q4 FY25 with US launch, $21M Southeast Asia deal, and retail expansion
29 July 2025
·Appendix 4C and Quarterly Activity Report
·85
EZZ Taps Aumake for Exclusive $10M Global Distribution DealMedium
EZZ appoints Aumake as exclusive global distributor with A$10M minimum purchase commitment
17 Feb 2026
·ASX Announcement
·75
EZZ Advances US Push Amid Q1 Sales Dip and New Product LaunchesMedium
EZZ reports softer Q1 sales, advances US entry, launches new products, maintains strong cash position
30 Oct 2025
·Appendix 4C and Quarterly Activity Report
·70
EZZ Life Science Posts Modest Revenue Rise Amid Profit DipMedium
EZZ Life Science posts modest revenue growth, slight profit decline, and raises net tangible assets per share
29 Aug 2025
·Appendix 4E Preliminary Final Report
·60
No articles in this tier for the last 12 months.